Eximia Research Expands Clinical Trial Network with Acquisition of Integrated Clinical Trial Services
核心洞察
Eximia Research (搜索) has acquired Integrated Clinical Trial Services (搜索) (ICTS) in Iowa, expanding its clinical trial network and enhancing access to advanced healthcare solutions.
ICTS, based in West Des Moines, brings 19 years of clinical research experience across multiple therapeutic areas, including pediatrics and metabolic disorders (搜索).
The acquisition aims to improve patient access to cutting-edge treatments and clinical trials in the Midwest, complementing Eximia's existing sites.
Eximia Research (搜索), an integrated clinical trial network, has broadened its reach with the acquisition of Integrated Clinical Trial Services (搜索) (ICTS) in West Des Moines, Iowa. This strategic move enhances Eximia's ability to deliver advanced clinical trials and healthcare solutions across the United States. The acquisition was announced on October 16, 2024, marking a significant step in Eximia's mission to improve access to innovative treatments nationwide.
ICTS, established in 2005 by Joe and Kristine Majors, operates as the only full-time dedicated research clinic in the Des Moines area. The clinic is known for its work across various therapeutic areas, including pediatrics, general medicine, neurology (搜索), pain management (搜索), sports medicine, dermatology, and metabolic disorders (搜索). ICTS has also played a crucial role in educating the public and medical professionals about the value of clinical trials.
Leadership and Expertise
Kristine Majors, a registered nurse with a Master of Science degree, brings extensive academic and clinical trial experience to Eximia. Her background includes serving as an associate professor at Des Moines University College of Osteopathic Medicine, where she led groundbreaking research. Together with her husband, Joe Majors, Kristine has developed ICTS into a multidisciplinary research site that has significantly contributed to the advancement of new treatments.
Strategic Impact and Future Outlook
Ella Grach, MD, CEO of Eximia Research (搜索), emphasized the strategic importance of this acquisition. "The addition of this established, successful site strengthens our ability to offer cutting-edge clinical trials to more communities and reinforces our commitment to expanding access to quality clinical research," said Grach. "With their experienced leadership and focus on patient care, particularly in pediatrics, metabolic disorders (搜索) and a wide range of other therapeutic areas, ICTS is a perfect fit for our growing network."
The integration of ICTS into Eximia's network is expected to provide patients in the West Des Moines area with enhanced access to clinical trials and advanced healthcare expertise. Kristine Majors expressed enthusiasm for the new chapter, stating, "By joining the Eximia network, we will have the support and resources to focus even more on what matters most—delivering exceptional care to our patients and advancing the field of clinical research."
This partnership complements Eximia's existing presence in the Midwest, including Sundance Clinical Research in St. Louis, and other sites across the Southeast, mid-Atlantic, and Western US. Eximia Research (搜索) is dedicated to delivering excellence in clinical trials across a wide range of therapeutic areas, focusing on quality data, patient safety, and operational efficiency.